Letybo

Croma

Letybo is developed by Hugel, Inc., a global leader in medical aesthetics founded in 2001. Specializing in the temporary improvement of moderate to severe glabellar lines (frown lines between the eyebrows), Letybo offers a refined formulation of letibotulinumtoxinA. This neuromodulator works by inhibiting acetylcholine release at the neuromuscular junction and reduces muscle activity that contributes to wrinkle formation. Each vial of Letybo contains either 50 or 100 units of letibotulinumtoxinA, along with albumin and sodium chloride. The products are supplied as a lyophilized powder.

select other brand

Skinfill Lalest ReNTox Neotox Zerotox Bienox Hutox Kamomis METOX Letybo Botulax Coretox Neuronox Innotox Nabota Newest Plinest Rich PL SAYPHA CINGAL DERMAHEAL Croma KYBELLA BELOTERO AQUASHINE ALIDYA ALIAXIN AESSOA Lemon Bottle Stylage Supartz Fx Synvisc Teosyal Cytocare Dr cyj hair filler Durolane Ejal40 Ellanse Fillmed GOURI HArmonyCa HYAcorp Jalupro Juvederm Karisma Mesoestetic Neauvia Nithya Nucleofill Orthovisc Perfectha Profhilo Radiesse Restylane Revolax Sculptra

Letybo (1x50 iu)

Botulinum toxin type A
(LetibotulinumtoxinA)
Strain CBFC26
1 x 50 U/Vial

Letybo 50 IU is a botulinum toxin type A product designed for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults.

Complexing Protein: Present (1st Generation)
Molecular Weight: 900 kD
Formulation: Powder for solution for injection
Diluent: 0.9% NaCl, 0.5% Human serum albumin
Strength/Conversion ratio: 1:1
Storage: 2-8° C

IS YOUR PRODUCT MISSING FROM OUR RANGE?

Get in touch to hear more about how to become a supplier.